Pierre Dupont and other researchers at Boston Children’s Hospital developed a small implantable robot that could help save babies born with esophageal atresia and other diseases.
A new nuclease inhibitor drug program could lead to the commercialization of novel DNA damage response (DDR) treatments for female breast, ovarian, and other types of cancers.
Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.
Join Marc Horner, Ph.D., Technical Lead, Healthcare at ANSYS, Inc. as he explains the concept of the digital twin and computational modeling as a critical element of modern healthcare in a free webinar on April 12.
Researchers use minibioreactor arrays to study the gut, coupling them with high-throughput screening techniques to examine the effects of different therapies on digestive system diseases. Reported by AABME.org
University of Illinois researchers combine biological muscles with structural frames that could open up possibilities for new types of robots and prosthesis. Reported by AABME.org.
Rice University researchers have found that breaking down a virus’s tough outer shell creates nanoparticles that could improve the delivery of chemotherapies and other medicines to diseased cells.
Northeastern University's Micropower and Nanoengineering Laboratory's new technique in origami folding to build 3D liver tissue constructs from flat sheets could mimic human organs and reduce time, expense, and testing needed to commercialize new pharmaceuticals.
Prosthetics are moving beyond simple mechanical functions and are becoming part of the human body itself.
Researchers at the University of California Los Angeles bioengineering department developed a tissue-based soft robot that resembles a stingray. The research is being used to transform regenerative medicine, as well as diagnostics and robotic systems that could function within the human body.
Dr. Patrick Hanley, assistant research professor of pediatrics in the Center for Cancer and Immunology research at the Children’s Research Institute in Washington D.C. and director of the Good Manufacturing Practices cell therapy laboratory at Children’s National Health System, on the new developments in the design and manufacturing for T cell therapies. He discussed ways in which technology can help simplify the methodologies and bring consistency and scalability to cell manufacturing.
More bioengineers are taking a serious look at how virtual and augmented reality tools, like Microsoft's HoloLens can expand their design capabilities, especially for medical imaging and computation, simulations, and implants and devices.
Georgia Tech Engineers created an organization to develop standards and production processes designed to mass produce life-saving cell-based therapeutics at affordable prices. Via AABME.
A new ultrasound technique that manipulates immune cells from outside the body could be the future of cancer care.
Duke University researchers have created human heart muscle in the laboratory, and successfully grown it large enough to provide a patch that contracts and transmits electrical signals.